BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33266177)

  • 1. Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy.
    Yang Y; Lundqvist A
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 Family Cytokines in Cancer and Immunotherapy.
    Mirlekar B; Pylayeva-Gupta Y
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33418929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-2 cytokine family in cancer immunotherapy.
    Sim GC; Radvanyi L
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):377-90. PubMed ID: 25200249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity.
    Tsukamoto H; Fujieda K; Senju S; Ikeda T; Oshiumi H; Nishimura Y
    Cancer Sci; 2018 Mar; 109(3):523-530. PubMed ID: 29090850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
    Mortara L; Balza E; Bruno A; Poggi A; Orecchia P; Carnemolla B
    Front Immunol; 2018; 9():2905. PubMed ID: 30619269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology of IL-12: coordinating innate and adaptive immune responses.
    Watford WT; Moriguchi M; Morinobu A; O'Shea JJ
    Cytokine Growth Factor Rev; 2003 Oct; 14(5):361-8. PubMed ID: 12948519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.
    Romee R; Leong JW; Fehniger TA
    Scientifica (Cairo); 2014; 2014():205796. PubMed ID: 25054077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biology and immunotherapy advance of interleukin 2 and interleukin 15-review].
    Chen GH; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1088-92. PubMed ID: 19698267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Stimulation with Interleukin-18 and Interleukin-12 Potently Induces Interleukin-8 Production by Natural Killer Cells.
    Poznanski SM; Lee AJ; Nham T; Lusty E; Larché MJ; Lee DA; Ashkar AA
    J Innate Immun; 2017; 9(5):511-525. PubMed ID: 28633138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y
    Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-27 in tumor immunity and immunotherapy.
    Murugaiyan G; Saha B
    Trends Mol Med; 2013 Feb; 19(2):108-16. PubMed ID: 23306374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s.
    Matsuzaki G; Umemura M
    Microbiol Immunol; 2018 Jan; 62(1):1-13. PubMed ID: 29205464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine regulation of natural killer cell effector functions.
    Zwirner NW; Domaica CI
    Biofactors; 2010; 36(4):274-88. PubMed ID: 20623510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs.
    Ganea D
    Adv Neuroimmunol; 1996; 6(1):61-74. PubMed ID: 8790782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 21 treatment in a murine model as a novel potential cytokine immunotherapy for colon cancer.
    Chen C; Liu X; Ren Y
    Adv Clin Exp Med; 2018 May; 27(5):583-589. PubMed ID: 29616746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.
    Lu B; Yang M; Wang Q
    J Mol Med (Berl); 2016 May; 94(5):535-43. PubMed ID: 26922618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
    Tormo AJ; Letellier MC; Lissilaa R; Batraville LA; Sharma M; Ferlin W; Elson G; Crabé S; Gauchat JF
    Cytokine; 2012 Dec; 60(3):653-60. PubMed ID: 22986012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells.
    Yu CR; Young HA; Ortaldo JR
    J Leukoc Biol; 1998 Aug; 64(2):245-58. PubMed ID: 9715265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2, IL-7, and IL-15: Multistage regulators of CD4(+) T helper cell differentiation.
    Read KA; Powell MD; McDonald PW; Oestreich KJ
    Exp Hematol; 2016 Sep; 44(9):799-808. PubMed ID: 27423815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.